Effect of Midazolam upon the Prevention of Nausea and Vomiting after Middle Ear Surgery / 대한마취과학회지
Korean Journal of Anesthesiology
;
: 550-555, 2007.
Artículo
en Coreano
| WPRIM
| ID: wpr-21120
ABSTRACT
BACKGROUND:
Midazolam has been reported to decrease postoperative nausea and vomiting (PONV). We studied the antiemetic effect of midazolam after middle ear surgery.METHODS:
In this prospective, randomized, double-blind, placebo-controlled study, 90 healthy patients were scheduled for middle ear surgery (tympanomastoidectomy and tympanoplasty). Patients were randomly divided into two groups; Midazolam 0.075 mg/kg (n = 45) or normal saline (n = 45) was administered after induction of anesthesia. The incidence of PONV, metoclopramide and ketorolac usage, pain, sedation, and other side effects were assessed at 6, 24 h after the operation.RESULTS:
The incidences of PONV were 15 (33%) in midazolam group and 27 (60%) in placebo group during 24 h postoperatively. The incidence of PONV in midazolam group was significantly lower than that in placebo group (P < 0.05). There were no significant differences between groups in adverse events.CONCLUSIONS:
Midazolam 0.075 mg/kg was effective for preventing PONV after middle ear surgery without significant adverse effects.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Vómitos
/
Midazolam
/
Incidencia
/
Estudios Prospectivos
/
Náusea y Vómito Posoperatorios
/
Ketorolaco
/
Oído Medio
/
Anestesia
/
Metoclopramida
/
Antieméticos
Tipo de estudio:
Ensayo Clínico Controlado
/
Estudio de incidencia
/
Estudio observacional
/
Estudio pronóstico
Límite:
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Anesthesiology
Año:
2007
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS